mometasone sandoz ninasprei, suspensioon
sandoz pharmaceuticals d.d. - mometasoon - ninasprei, suspensioon - 50mcg 1mõõtannus 140mõõtannus 3tk; 50mcg 1mõõtannus 140mõõtannus 2tk; 50mcg 1mõõtannus 60mõõtannus 1tk; 50mcg 1mõõtannus 120mõõtannus 1tk; 50mcg 1mõõtannus 140mõõtannus 1tk
mometasone teva ninasprei, suspensioon
teva pharma b.v. - mometasoon - ninasprei, suspensioon - 50mcg 1annus 140annus 1tk; 50mcg 1annus 120annus 1tk; 50mcg 1annus 140annus 3tk
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
elocon kreem
organon n.v. - mometasoon - kreem - 1mg 1g 30g 1tk; 1mg 1g 50g 1tk; 1mg 1g 20g 1tk
elocon nahalahus
organon n.v. - mometasoon - nahalahus - 1mg 1g 20ml 1tk; 1mg 1g 50ml 1tk
elocon salv
organon n.v. - mometasoon - salv - 1mg 1g 20g 1tk; 1mg 1g 50g 1tk
frondava nahaemulsioon
almirall hermal gmbh - mometasoon - nahaemulsioon - 1mg 1g 50g 1tk; 1mg 1g 100g 1tk; 1mg 1g 20g 1tk
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - ravimid hingamisteede obstruktiivsete haiguste, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.